<p>联合健康集团（Unitedhealth Group Inc.）已召开第一季度财报电话会议。请继续阅读会议的主要亮点。</p>
<h3>在 TipRanks 上享受 30% 折扣</h3>
<ul>
<li>解锁对冲基金级别的数据和强大的投资工具，以做出更聪明、更精准的决策</li>
<li>发现表现优异的股票投资理念，并升级到市场领先者的投资组合，使用智能投资者精选</li>
</ul>
<p>联合健康集团最新的财报电话会议传达了一种谨慎乐观的基调，管理层在利润明显超出预期和运营改善与持续的利用、资金和监管压力之间取得了平衡。高管们指出了严格的定价、现金实力以及数字和人工智能的加速增长，同时警告称，严重的上半年季节性和已知压力可能使早期的势头难以维持。</p>
<h2>调整后每股收益超出预期及更新展望</h2>
<p>联合健康第一季度的调整后每股收益为 7.23 美元，远超市场预期，使公司有信心将全年 GAAP 调整后每股收益展望上调至 18.25 美元以上。管理层将这一超出预期的表现视为成本措施、Optum 执行和前一年发展收益开始恢复利润率势头的证据，尽管基于 2025 年的挑战性基础。</p>
<h2>收入增长和强劲的现金生成</h2>
<p>季度收入达到 1117 亿美元，同比增长 2%，尽管增幅温和，但仍支撑了盈利的意外。更大的故事是现金：经营现金流为 89 亿美元，是净收入的 1.4 倍，给予公司充足的灵活性以继续投资于增长计划，同时向股东返还资本。</p>
<h2>改善的医疗费用比率显示更好的成本控制</h2>
<p>医疗费用比率从一年前的 84.8% 改善至 83.9%，大约提高了 90 个基点，反映出更严格的定价纪律和更好的医疗成本管理。前一年储备的有利发展也有所帮助，管理层强调，维持这一水平需要持续的警惕，因为潜在趋势仍然较高。</p>
<h2>Optum Health 的运营转型获得进展</h2>
<p>Optum Health 产生了 13 亿美元的调整后收益，领导层强调了护理管理和临床工作流程的显著运营转型。在一个地区，熟练护理设施的入院人数在新项目的第一个月下降了约 35%，而临床审查增加了超过 50%，患者接触时间同比增长 12%，暗示护理协调的改善。</p>
<h2>数字化采用和简化的事前授权</h2>
<p>数字参与正成为该业务的核心，近一半的联合健康保险成员现在已注册数字访问，季度内数字访问达到 7300 万次，同比增长 42%。超过 80% 的消费者联系是数字化的，约 95% 的事前授权是电子提交的，约一半实时处理，超过 90% 在一个工作日内获得批准。</p>
<h2>Optum Rx 客户赢得和人工智能驱动的效率</h2>
<p>Optum Rx 在年初迎来了超过 800 个新客户的入驻，尽管政策背景艰难，仍显示出在药房服务方面的持续市场份额增长。数字和人工智能工具将呼叫中心的工作量减少了 25%，同时保持会员满意度在 95% 以上，PreCheck PA 解决方案现在将处方批准时间从超过 8 小时缩短至不到 30 秒，显著减少了拒绝和上诉。</p>
<h2>人工智能投资策略和早期回报</h2>
<p>联合健康计划在 2026 年投资近 15 亿美元于人工智能项目，随着产品在 Optum 和联合健康保险中的扩展，Optum Real 平台今年迄今已处理约 5 亿笔交易，目标是在年末前超过 25 亿笔，管理层预计许多人工智能项目在未来几年将产生保守的回报，每投资 1 美元将产生至少 2 美元的回报。</p>
<h2>资本配置纪律和资产负债表去杠杆化</h2>
<p>资产负债表持续增强，债务与资本比率改善至 42.9%，并朝着年末 40% 的目标迈进。联合健康还比之前计划的更早开始回购股票，并预计在第二季度末之前部署至少 20 亿美元，同时在并购和战略资本支出方面保持谨慎态度。</p>
<h2>会员收缩和产品组合变化</h2>
<p>美国会员人数从 2025 年底的 4980 万下降至 4910 万，管理层重申预计今年将损失约 130 万名会员，主要集中在医疗保险领域。高管们将此视为一种有意的重置，以使定价和福利与潜在成本保持一致，暗示每位会员的收入应在总会员减少的情况下上升。</p>
<h2>ACA 个人业务收缩</h2>
<p>在《平价医疗法案》个人市场中，联合健康预计其业务将在 2026 年缩减约三分之一，因为它收缩并将产品重点放在青铜和黄金层次。公司强调在这一波动的细分市场中更可持续的利润结构，并承诺对这些计划的未来利润采取保守的态度。</p>
<h2>医疗补助面临资金和趋势压力</h2>
<p>医疗补助仍然是一个薄弱环节，管理层警告称，医疗趋势的上升和滞后的州资金可能会在 2026 年导致负利润。虽然随着重新确定资格的进展，预计会有一些会员流失，但公司预计到 2027 年仅会有适度的利润缓解，使医疗补助成为一个多年的修复故事。</p>
<h2>持续上升的医疗成本趋势</h2>
<p>潜在的利用率，特别是在医疗保险优势计划中，并未从 2025 年的水平上显著缓解，趋势仍然在 7% 到 8% 之间，而定价假设接近 10%。联合健康在严格定价、更紧的福利设计和增强的护理管理方面投入了大量精力以弥补差距，但承认高企的趋势仍然是一个结构性阻力。</p>
<h2>短期运营成本和激励补偿激增</h2>
<p>本季度运营成本比率上升至 13.8%，反映了针对性投资和激励薪酬的大幅增加，激励薪酬达到了约 9 亿美元，而去年同期仅为 3500 万美元。管理层认为这些成本在很大程度上是前期投入，并与生产力和留存计划相关，这些计划应该会随着时间的推移带来收益，即使它们暂时抬高了费用比率。</p>
<h2>季节性和一次性利好因素影响比较</h2>
<p>第一季度的业绩受益于呼吸道活动略低于预期，以及去年同期的有利发展，超过 5 亿美元。高管们警告称，这些季节性和一次性利好因素在今年后期不太可能以相同的水平重现，这意味着投资者在将第一季度的强劲表现外推到下半年时应谨慎。</p>
<h2>监管和政策风险隐现</h2>
<p>管理层强调了日益复杂的政策背景，提到了新兴的药品福利管理者规则和州级立法，以及对医疗保险优势风险模型的潜在变化。虽然联合健康表示已将当前提案纳入其指导中，但高管们承认，监管变化仍可能影响准入、定价和长期盈利能力。</p>
<h2>下半年收益和细分市场季节性</h2>
<p>2026 年的收益结构 heavily front-loaded，预计约三分之二的利润将在上半年产生，而联合健康的收益中超过 75% 将集中在这一时期。相比之下，Optum Insight 和 Optum Rx 预计将在下半年产生约 60% 的收益，这将导致医疗费用比率和同比比较的显著季节性波动。</p>
<h2>指导和前瞻性展望</h2>
<p>在强劲的第一季度之后，联合健康重申并略微调整了其全年计划，涵盖每股收益、现金生成、人工智能部署和资本回报，同时重申约三分之二的 2026 年收益将在上半年实现。管理层维持了 Optum Health 的长期利润目标，概述了明年计划投资约 15 亿美元于人工智能，确认到第二季度末至少进行 20 亿美元的股票回购，并坚持其降低杠杆的路径，目标为 40% 的债务资本比率。</p>
<p>联合健康的财报电话会议描绘了一幅财务稳健的公司图景，利用数字和人工智能工具在艰难的利用率和政策环境中重建利润率。尽管会员人数在减少，医疗补助、平价医疗法案和监管风险仍然是重要的压力因素，但强劲的现金流、改善的成本比率和有序的资本部署为管理层提供了应对的空间，使投资者对未来持谨慎乐观的展望。</p>

联合健康

医疗业 ETF - Vanguard

医疗业 ETF - SPDR

标普医疗保健服务 ETF - SPDR

美国医疗保健供应商 ETF - iShares

标普全球医疗股指数 ETF - iShares

UNHG

<p>联合健康集团的第一季度财报电话会议透露出谨慎的乐观情绪，调整后的每股收益为 7.23 美元，超出预期，并提高了全年展望。收入增长 2%，达到 1117 亿美元，强劲的现金流为 89 亿美元提供了支持。医疗护理比例改善，表明成本控制更为有效。Optum Health 显示出运营上的增长，而数字参与度激增。联合健康计划到 2026 年投资 15 亿美元于人工智能。然而，会员人数有所下降，尤其是在医疗保险方面，预计到 2026 年，平价医疗法案个人市场将缩减三分之一。医疗补助面临资金和趋势方面的挑战</p>

<p>Unitedhealth Group Inc. ((UNH)) has held its Q1 earnings call. Read on for the main highlights of the call.</p>
<div class="lb-trans"><p>联合健康集团（Unitedhealth Group Inc.）已召开第一季度财报电话会议。请继续阅读会议的主要亮点。</p>
</div><h3>Claim 30% Off TipRanks</h3>
<div class="lb-trans"><h3>在 TipRanks 上享受 30% 折扣</h3>
</div><ul>
<li>Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions</li>
<li>Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks</li>
</ul>
<div class="lb-trans"><ul>
<li>解锁对冲基金级别的数据和强大的投资工具，以做出更聪明、更精准的决策</li>
<li>发现表现优异的股票投资理念，并升级到市场领先者的投资组合，使用智能投资者精选</li>
</ul>
</div><p>UnitedHealth Group’s latest earnings call struck a tone of cautious optimism as management balanced a clear beat on profits and improving operations against persistent headwinds in utilization, funding, and regulation. Executives pointed to disciplined pricing, cash strength, and accelerating digital and AI gains, while warning that heavy first‑half seasonality and known pressures could make the early momentum hard to sustain.</p>
<div class="lb-trans"><p>联合健康集团最新的财报电话会议传达了一种谨慎乐观的基调，管理层在利润明显超出预期和运营改善与持续的利用、资金和监管压力之间取得了平衡。高管们指出了严格的定价、现金实力以及数字和人工智能的加速增长，同时警告称，严重的上半年季节性和已知压力可能使早期的势头难以维持。</p>
</div><h2>Adjusted EPS Beat and Updated Outlook</h2>
<div class="lb-trans"><h2>调整后每股收益超出预期及更新展望</h2>
</div><p>UnitedHealth posted adjusted EPS of $7.23 for the first quarter, well ahead of market expectations and giving the company enough confidence to raise its full‑year GAAP‑adjusted EPS outlook to above $18.25. Management framed the beat as evidence that cost actions, Optum execution, and prior‑year development benefits are beginning to restore margin momentum, albeit from a challenged 2025 base.</p>
<div class="lb-trans"><p>联合健康第一季度的调整后每股收益为 7.23 美元，远超市场预期，使公司有信心将全年 GAAP 调整后每股收益展望上调至 18.25 美元以上。管理层将这一超出预期的表现视为成本措施、Optum 执行和前一年发展收益开始恢复利润率势头的证据，尽管基于 2025 年的挑战性基础。</p>
</div><h2>Revenue Growth and Strong Cash Generation</h2>
<div class="lb-trans"><h2>收入增长和强劲的现金生成</h2>
</div><p>Quarterly revenue reached $111.7 billion, a modest 2% year‑over‑year increase that nonetheless underpinned the earnings surprise. The bigger story was cash: operating cash flow came in at $8.9 billion, or 1.4 times net income, giving the company ample flexibility to keep investing in growth initiatives while returning capital to shareholders.</p>
<div class="lb-trans"><p>季度收入达到 1117 亿美元，同比增长 2%，尽管增幅温和，但仍支撑了盈利的意外。更大的故事是现金：经营现金流为 89 亿美元，是净收入的 1.4 倍，给予公司充足的灵活性以继续投资于增长计划，同时向股东返还资本。</p>
</div><h2>Improved Medical Care Ratio Signals Better Cost Control</h2>
<div class="lb-trans"><h2>改善的医疗费用比率显示更好的成本控制</h2>
</div><p>The medical care ratio improved to 83.9% from 84.8% a year ago, a roughly 90‑basis‑point gain that reflects tighter pricing discipline and better medical cost management. Favorable prior‑year reserve development also helped, and management stressed that sustaining this level will require continued vigilance as underlying trends remain elevated.</p>
<div class="lb-trans"><p>医疗费用比率从一年前的 84.8% 改善至 83.9%，大约提高了 90 个基点，反映出更严格的定价纪律和更好的医疗成本管理。前一年储备的有利发展也有所帮助，管理层强调，维持这一水平需要持续的警惕，因为潜在趋势仍然较高。</p>
</div><h2>Optum Health’s Operational Turnaround Gains Traction</h2>
<div class="lb-trans"><h2>Optum Health 的运营转型获得进展</h2>
</div><p>Optum Health generated adjusted earnings of $1.3 billion, with leadership highlighting a notable operational turnaround in care management and clinical workflows. In one region, skilled nursing facility admissions dropped about 35% in the first month of new programs, while clinical reviews climbed more than 50% and patient‑facing hours rose 12% year over year, hinting at improved care coordination.</p>
<div class="lb-trans"><p>Optum Health 产生了 13 亿美元的调整后收益，领导层强调了护理管理和临床工作流程的显著运营转型。在一个地区，熟练护理设施的入院人数在新项目的第一个月下降了约 35%，而临床审查增加了超过 50%，患者接触时间同比增长 12%，暗示护理协调的改善。</p>
</div><h2>Digital Adoption and Streamlined Prior Authorization</h2>
<div class="lb-trans"><h2>数字化采用和简化的事前授权</h2>
</div><p>Digital engagement is becoming core to the franchise, with nearly half of UnitedHealthcare members now registered for digital access and 73 million digital visits in the quarter, up 42% over two years. More than 80% of consumer contacts are digital, and about 95% of prior authorizations are submitted electronically, with roughly half processed in real time and over 90% approved within a business day.</p>
<div class="lb-trans"><p>数字参与正成为该业务的核心，近一半的联合健康保险成员现在已注册数字访问，季度内数字访问达到 7300 万次，同比增长 42%。超过 80% 的消费者联系是数字化的，约 95% 的事前授权是电子提交的，约一半实时处理，超过 90% 在一个工作日内获得批准。</p>
</div><h2>Optum Rx Client Wins and AI‑Driven Efficiency</h2>
<div class="lb-trans"><h2>Optum Rx 客户赢得和人工智能驱动的效率</h2>
</div><p>Optum Rx opened the year with more than 800 new client onboardings, signaling continued share gains in pharmacy services despite a tough policy backdrop. Digital and AI tools have cut contact center volume by 25% while maintaining member satisfaction above 95%, and the PreCheck PA solution now shrinks prescription approval times from over eight hours to under 30 seconds, sharply reducing denials and appeals.</p>
<div class="lb-trans"><p>Optum Rx 在年初迎来了超过 800 个新客户的入驻，尽管政策背景艰难，仍显示出在药房服务方面的持续市场份额增长。数字和人工智能工具将呼叫中心的工作量减少了 25%，同时保持会员满意度在 95% 以上，PreCheck PA 解决方案现在将处方批准时间从超过 8 小时缩短至不到 30 秒，显著减少了拒绝和上诉。</p>
</div><h2>AI Investment Strategy and Early Returns</h2>
<div class="lb-trans"><h2>人工智能投资策略和早期回报</h2>
</div><p>UnitedHealth plans to invest nearly $1.5 billion in AI initiatives in 2026 as it scales products across Optum and UnitedHealthcare. The Optum Real platform has already processed around 0.5 billion transactions year‑to‑date, with a goal of surpassing 2.5 billion by year‑end, and management expects many AI programs to generate conservative returns of at least two dollars for every dollar invested over the next few years.</p>
<div class="lb-trans"><p>联合健康计划在 2026 年投资近 15 亿美元于人工智能项目，随着产品在 Optum 和联合健康保险中的扩展，Optum Real 平台今年迄今已处理约 5 亿笔交易，目标是在年末前超过 25 亿笔，管理层预计许多人工智能项目在未来几年将产生保守的回报，每投资 1 美元将产生至少 2 美元的回报。</p>
</div><h2>Capital Allocation Discipline and Balance Sheet Deleveraging</h2>
<div class="lb-trans"><h2>资本配置纪律和资产负债表去杠杆化</h2>
</div><p>The balance sheet continued to strengthen, with the debt‑to‑capital ratio improving to 42.9% and on track toward a 40% target by year‑end. UnitedHealth also began share repurchases earlier than previously planned and expects to deploy at least $2 billion by the end of the second quarter, while keeping a measured stance on M&amp;A and strategic capital spending.</p>
<div class="lb-trans"><p>资产负债表持续增强，债务与资本比率改善至 42.9%，并朝着年末 40% 的目标迈进。联合健康还比之前计划的更早开始回购股票，并预计在第二季度末之前部署至少 20 亿美元，同时在并购和战略资本支出方面保持谨慎态度。</p>
</div><h2>Membership Contraction and Product Mix Shifts</h2>
<div class="lb-trans"><h2>会员收缩和产品组合变化</h2>
</div><p>U.S. membership slipped to 49.1 million from 49.8 million at the end of 2025, and management reaffirmed expectations for roughly 1.3 million members to be lost this year, largely in Medicare. Executives positioned this as a deliberate reset to align pricing and benefits with underlying costs, suggesting revenue per member should rise even as total membership falls.</p>
<div class="lb-trans"><p>美国会员人数从 2025 年底的 4980 万下降至 4910 万，管理层重申预计今年将损失约 130 万名会员，主要集中在医疗保险领域。高管们将此视为一种有意的重置，以使定价和福利与潜在成本保持一致，暗示每位会员的收入应在总会员减少的情况下上升。</p>
</div><h2>ACA Individual Business Pullback</h2>
<div class="lb-trans"><h2>ACA 个人业务收缩</h2>
</div><p>In the Affordable Care Act individual market, UnitedHealth expects its business to shrink by about one‑third in 2026 as it retrenches and focuses offerings on bronze and gold tiers. The company is emphasizing a more sustainable margin profile in this volatile segment and has committed to a conservative approach to any future profits from these plans.</p>
<div class="lb-trans"><p>在《平价医疗法案》个人市场中，联合健康预计其业务将在 2026 年缩减约三分之一，因为它收缩并将产品重点放在青铜和黄金层次。公司强调在这一波动的细分市场中更可持续的利润结构，并承诺对这些计划的未来利润采取保守的态度。</p>
</div><h2>Medicaid Under Pressure from Funding and Trends</h2>
<div class="lb-trans"><h2>医疗补助面临资金和趋势压力</h2>
</div><p>Medicaid remains a weak spot, with management warning that elevated medical trends and lagging state funding will likely drive negative margins in 2026. While some attrition in membership is expected as redeterminations progress, the company anticipates only modest margin relief beginning in 2027, making Medicaid a multiyear repair story.</p>
<div class="lb-trans"><p>医疗补助仍然是一个薄弱环节，管理层警告称，医疗趋势的上升和滞后的州资金可能会在 2026 年导致负利润。虽然随着重新确定资格的进展，预计会有一些会员流失，但公司预计到 2027 年仅会有适度的利润缓解，使医疗补助成为一个多年的修复故事。</p>
</div><h2>Persistently Elevated Medical Cost Trends</h2>
<div class="lb-trans"><h2>持续上升的医疗成本趋势</h2>
</div><p>Underlying utilization, particularly in Medicare Advantage, has not eased materially from 2025 levels, with trends still cited around 7% to 8% against pricing assumptions closer to 10%. UnitedHealth is leaning heavily on disciplined pricing, tighter benefit design, and enhanced care management to bridge the gap, but acknowledged that elevated trends remain a structural headwind.</p>
<div class="lb-trans"><p>潜在的利用率，特别是在医疗保险优势计划中，并未从 2025 年的水平上显著缓解，趋势仍然在 7% 到 8% 之间，而定价假设接近 10%。联合健康在严格定价、更紧的福利设计和增强的护理管理方面投入了大量精力以弥补差距，但承认高企的趋势仍然是一个结构性阻力。</p>
</div><h2>Near‑Term Operating Costs and Incentive Compensation Spike</h2>
<div class="lb-trans"><h2>短期运营成本和激励补偿激增</h2>
</div><p>The operating cost ratio rose to 13.8% in the quarter, reflecting both targeted investments and a sizeable jump in incentive compensation, which reached about $900 million versus just $35 million in the prior‑year period. Management argued these costs are largely front‑loaded and tied to productivity and retention programs that should yield benefits over time, even as they temporarily inflate expense ratios.</p>
<div class="lb-trans"><p>本季度运营成本比率上升至 13.8%，反映了针对性投资和激励薪酬的大幅增加，激励薪酬达到了约 9 亿美元，而去年同期仅为 3500 万美元。管理层认为这些成本在很大程度上是前期投入，并与生产力和留存计划相关，这些计划应该会随着时间的推移带来收益，即使它们暂时抬高了费用比率。</p>
</div><h2>Seasonality and One‑Time Tailwinds Cloud Comparisons</h2>
<div class="lb-trans"><h2>季节性和一次性利好因素影响比较</h2>
</div><p>First‑quarter results benefited from modestly lighter‑than‑expected respiratory activity as well as favorable prior‑year development of slightly more than $500 million. Executives cautioned that these seasonal and one‑time tailwinds are unlikely to recur at the same level later in the year, meaning investors should be careful extrapolating Q1 strength into the back half.</p>
<div class="lb-trans"><p>第一季度的业绩受益于呼吸道活动略低于预期，以及去年同期的有利发展，超过 5 亿美元。高管们警告称，这些季节性和一次性利好因素在今年后期不太可能以相同的水平重现，这意味着投资者在将第一季度的强劲表现外推到下半年时应谨慎。</p>
</div><h2>Regulatory and Policy Risks Loom</h2>
<div class="lb-trans"><h2>监管和政策风险隐现</h2>
</div><p>Management underscored an increasingly complex policy backdrop, citing emerging pharmacy benefit manager rules and state‑level legislation along with potential changes to Medicare Advantage risk models. While UnitedHealth says it has baked current proposals into its guidance, executives acknowledged that shifting regulation could still affect access, pricing, and longer‑term earnings power.</p>
<div class="lb-trans"><p>管理层强调了日益复杂的政策背景，提到了新兴的药品福利管理者规则和州级立法，以及对医疗保险优势风险模型的潜在变化。虽然联合健康表示已将当前提案纳入其指导中，但高管们承认，监管变化仍可能影响准入、定价和长期盈利能力。</p>
</div><h2>Back‑Half Earnings and Segment Seasonality</h2>
<div class="lb-trans"><h2>下半年收益和细分市场季节性</h2>
</div><p>The earnings profile for 2026 is heavily front‑loaded, with roughly two‑thirds of profits expected in the first half and more than 75% of UnitedHealthcare’s earnings weighted to that period. By contrast, Optum Insight and Optum Rx are expected to generate around 60% of their earnings in the second half, setting up pronounced seasonal swings in medical care ratios and year‑over‑year comparisons.</p>
<div class="lb-trans"><p>2026 年的收益结构 heavily front-loaded，预计约三分之二的利润将在上半年产生，而联合健康的收益中超过 75% 将集中在这一时期。相比之下，Optum Insight 和 Optum Rx 预计将在下半年产生约 60% 的收益，这将导致医疗费用比率和同比比较的显著季节性波动。</p>
</div><h2>Guidance and Forward‑Looking Outlook</h2>
<div class="lb-trans"><h2>指导和前瞻性展望</h2>
</div><p>Following the strong first quarter, UnitedHealth reaffirmed and slightly sharpened its full‑year playbook around EPS, cash generation, AI deployment, and capital returns, while reiterating that about two‑thirds of 2026 earnings will land in the first half. Management maintained long‑term margin targets for Optum Health, outlined planned AI investment near $1.5 billion next year, confirmed at least $2 billion in share buybacks by end‑Q2, and stuck to its deleveraging path toward a 40% debt‑to‑capital ratio.</p>
<div class="lb-trans"><p>在强劲的第一季度之后，联合健康重申并略微调整了其全年计划，涵盖每股收益、现金生成、人工智能部署和资本回报，同时重申约三分之二的 2026 年收益将在上半年实现。管理层维持了 Optum Health 的长期利润目标，概述了明年计划投资约 15 亿美元于人工智能，确认到第二季度末至少进行 20 亿美元的股票回购，并坚持其降低杠杆的路径，目标为 40% 的债务资本比率。</p>
</div><p>UnitedHealth’s earnings call painted a picture of a financially robust company using digital and AI tools to rebuild margins in a tough utilization and policy environment. While membership is shrinking and Medicaid, ACA, and regulatory risks remain meaningful overhangs, strong cash flow, improving cost ratios, and disciplined capital deployment give management room to navigate, leaving investors with a cautiously constructive outlook.</p>
<div class="lb-trans"><p>联合健康的财报电话会议描绘了一幅财务稳健的公司图景，利用数字和人工智能工具在艰难的利用率和政策环境中重建利润率。尽管会员人数在减少，医疗补助、平价医疗法案和监管风险仍然是重要的压力因素，但强劲的现金流、改善的成本比率和有序的资本部署为管理层提供了应对的空间，使投资者对未来持谨慎乐观的展望。</p>
</div>

联合健康集团的财报电话会议显示出谨慎的反弹迹象